Disclosure Of Cash Flow Statement [Text Block]

ROQUEFORT THERAPEUTICS PLC - Filing #5968009

Concept As at
2024-12-31
2024-01-01 to
2024-12-31
As at
2023-12-31
As at
2022-12-31
Disclosure of cash flow statement [text block]
Description of accounting policy for determining components of cash and cash equivalents [text block]
Cash and cash equivalents if different from statement of financial position [abstract]
Cash and cash equivalents
337,112 GBP
537,322 GBP
2,322,974 GBP

Talk to a Data Expert

Have a question? We'll get back to you promptly.